Glaukos Corp 2025年季度报告

(Mark One)☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 For the quarterly period endedMarch 31, 2025or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIESEXCHANGE ACT OF 1934 Commission file number:001-37463 GLAUKOS CORPORATION(Exact name of registrant as specified in its charter) Delaware(State or other jurisdiction ofincorporation or organization) 33-0945406(I.R.S. Employer Identification No.) (949)367-9600(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) ofthe Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant wasrequired to file such reports), and (2) has been subject to such filing requirements for the past 90 days.Yes⌧No◻ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required tobe submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or forsuch shorter period that the registrant was required to submit such files).Yes⌧No◻ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-acceleratedfiler, a smaller reporting company or an emerging growth company. See the definitions of ‘‘large accelerated filer,’’‘‘accelerated filer,’’ ‘‘smaller reporting company’’ and “emerging growth company” in Rule 12b-2 of the Exchange Act: ☒Large accelerated filer☐Accelerated filer☐Non-accelerated filer☐Smaller reporting company ☐Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extendedtransition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒ As of April 29, 2025, there were57,140,526shares of the registrant’s Common Stock, $0.001 par value per share,outstanding. GLAUKOS CORPORATIONForm 10-QFor the Quarterly Period Ended March 31, 2025Table of Contents Page PART I:FINANCIAL INFORMATION5Item1.Financial Statements5Condensed Consolidated Balance Sheets5Condensed Consolidated Statements of Operations6Condensed Consolidated Statements of Comprehensive Loss7Condensed Consolidated Statements of Stockholders’ Equity8Condensed Consolidated Statements of Cash Flows9Notes to Condensed Consolidated Financial Statements10Item2.Management’s Discussion and Analysis of Financial Condition and Results ofOperations24Item3.Quantitative and Qualitative Disclosures About Market Risk33Item4.Controls and Procedures34 PART II:OTHER INFORMATION35Item1.Legal Proceedings35Item1A.Risk Factors35Item6.Exhibits52 Note Regarding Forward-Looking Statements This report contains forward-looking statements within the meaning of Section 27A of theSecurities Act of 1933, as amended (Securities Act), and Section 21E of the Securities Exchange Actof 1934, as amended (Exchange Act) All statements other than statements of historical or currentfacts included in this report are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: "may," "will," "could," "would," "should," "expect,""intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue,""ongoing" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Any statements in this Quarterly Report on Form 10-Qregardingfuture operations, including our expectations for future expenses, capital expenditures andincome, our expectations regarding the impact of the macroeconomic environment, our strategy forgrowth, product development activities, the impact of the regulatory environment, including thetiming and likelihood of regulatory approvals and the impact of new or changing regulations andpricing, and market positionare forward-looking statements. These forward-looking statements arebased on management’s beliefs and assumptions based on the information available to managementat the time of this report. Although we believe that we have a reasonable basis for each forward-looking statement contained in this report, we caution you that these forward-looking statementsinvolve risks, uncertainties and other factors that may cause actual results, levels of activity,performance or achievements to be materially different from the information expressed or implied bythese forward-looking statements. You are urged to carefully review the disclosures we make concerning the risks we face andother factors that may affect the outcome of our forward-looking statements and our business andoperating results, including the ris